[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, LY6K overexpression is not associated with a better prognosis for non-small cell lung cancer (NSCLC) patients. Document [0] states that LY6K overexpression is associated with poor prognosis for patients with NSCLC. Document [1] also supports this by stating that LY6K is an anti-gene in NSCLC and its increase is correlated with the progression of cancer. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]